Portfolio
Immutep
Immutep is a biologics company in the fast-growing field of targeted protein-based immunotherapeutics. The Company is well-advanced in the clinic and is planning a Phase IIb or III trial. It is based near Paris, France, and is staffed with 8 professionals. It has raised € 7.1 million in equity and has been awarded € 1.7 million in grants.
| Industry : | biothérapeutiques |
| Location : | Paris, France |
| Funds : | Innoven FCPI 2001, 2002. FCPI Poste Innovation 1, 2, 3 |
| Contact: | Thomas Balland |
Read more about :
Immutep
30/05/2006